Flynn Zito Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Flynn Zito Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,881	Closed	-$205K	–	76
2022 Q3	$205K	Buy	+2,881	New	+$209K	0.2%	57
2022 Q2	–	Sell	-3,331	Closed	-$243K	–	70
2022 Q1	$243K	Sell	3,331 -400	-11%	-$26.9K	0.21%	58
2021 Q4	$233K	Buy	+3,731	New	+$219K	0.2%	64

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Flynn Zito Capital Management's BMY Position: Q4 2022 in Review

Flynn Zito Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 2,881 shares — an estimated $205K sold.

Flynn Zito Capital Management first reported a position in BMY in Q4 2021 and held it in 3 quarters. The position peaked at $243K in Q1 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

Flynn Zito Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
Flynn Zito Capital Management sold 2,881 Bristol-Myers Squibb shares in Q4 2022, an estimated $205K.
Flynn Zito Capital Management first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 3 quarters.
Flynn Zito Capital Management's Bristol-Myers Squibb position peaked at $243K in Q1 2022.
2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Flynn Zito Capital Management's 13F filing for Q4 2022, filed 30 Jan 2023.